设为首页收藏本站

中国病毒学论坛|我们一直在坚持!

 找回密码
 立即注册

QQ登录

只需一步,快速开始

搜索
热搜: 活动 交友 discuz
查看: 2229|回复: 5
打印 上一主题 下一主题

疫苗学《Vaccines》——6th Edition by (美)普洛特金

[复制链接]

1067

帖子

1032

学分

1万

金币

管理员

Rank: 9Rank: 9Rank: 9Rank: 9

积分
1032
QQ
跳转到指定楼层
楼主
发表于 2015-7-25 14:07:34 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
* L! o4 m& \' Y9 }  u6 B  b
Vaccines, 6th Edition

, d/ n( ~3 }* b: J" c* ]Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.  Z& C4 _7 V3 G

4 }. W4 M( j% O
http://yun.baidu.com/share/link?shareid=2079860221&uk=38109966067 L$ W: ~0 o$ e' E- J: U

1 a9 L' w  ]* j: LSECTION 1: General aspects of vaccination
4 U2 Z+ e2 O6 E5 O1 A short history of vaccination 1
8 t6 B7 _3 g, J5 e5 G  e2 Vaccine immunology 14
1 o6 W2 o; R% D6 c: Q% j3 The vaccine industry 33
2 ^0 W5 `  t, s; Y- d! O4 Vaccine manufacturing 44
& z. ]. ~! c$ `$ R" w" s( E5 Evolution of adjuvants across the centuries 58
: A/ h7 U; h4 F  r# [6 \2 C* }8 M6 Vaccine additives and manufacturing residuals in the United States:
0 P6 I) k  Y5 p2 ^* }5 P9 c% flicensed vaccines 71
8 i& j4 U1 l; n7 Passive immunization 80
. p. S' V( `' O2 e- L# c( a) ]8 General immunization practices 88
  a& z8 }3 P. a- |# X. uSECTION 2: Licensed vaccines
( L& I& A/ D9 X8 W/ F9 Adenovirus vaccines 113
% t6 |& ]# B/ G* x0 d1 |4 N10 Anthrax vaccines 1270 t% w* o- l5 J) n+ [2 h5 O' d
11 Cholera vaccines 141$ |' j9 A/ |  z7 W
12 Diphtheria toxoid 153% G# ?1 B2 l% c# m5 U
13 Haemophilus influenzae vaccines 167; {0 h' }, r, L+ o$ {' O$ O
14 Hepatitis A vaccines 183' g6 r# W" s  Y, D9 \2 h7 x
15 Hepatitis B vaccines 205* t7 g: d' @0 T# G7 U. L4 r
16 Human papillomavirus vaccines 235. d8 M- k, q$ M- O9 ?! A
17 Inactivated influenza vaccines 257
+ T' \8 q# x& |+ R" d7 K3 |: y18 Influenza vaccine-live 294. ^' Q2 h' J; R- p9 e
19 Japanese encephalitis vaccines 312
' x. P: {6 m8 a& L20 Measles vaccines 352
8 {, W+ ?& \! G1 i: q: T% d2 P21 Meningococcal vaccines 388
1 g8 V+ W! q5 G) p, L: v22 Mumps vaccine 4199 N# t( K; Y2 D: e) Q' T8 R8 c
23 Pertussis vaccines . 447
/ j$ F5 j3 m# `) V" [/ v24 Plague vaccines 493
- j; C9 ]4 F, E5 D7 m6 M1 u0 h25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
+ [" Q7 _8 }6 k) N2 h# K/ o26 Pneumococcal polysaccharide vaccines 542
- k+ `5 ^' T8 D. ]27 Poliovirus vaccine-inactivated . 573# S8 h/ w6 _& i- m* Q2 C
28 Poliovirus vaccine-live 598. _$ U% W$ o/ U- Y- T  R
29 Rabies vaccines .646
3 B+ j" T8 O. N# @8 C0 I30 Rotavirus vaccines . 669, ]) r; {9 n: a& Z- N0 k9 v
31 Rubella vaccine 688
( j4 ^" i" e$ ]5 h32 Smallpox and vaccinia 718) _' U' R$ \9 I7 ]1 @& G
33 Tetanus toxoid 746
7 x) Q: V7 g5 K2 X34 Tick-borne encephalitis virus vaccines 773" {% f. H: t. A; q1 S
35 Tuberculosis vaccines 789- {6 Z; F6 _2 v; V) ~
36 Typhoid fever vaccines 812; D! a4 R. {8 r' S
37 Varicella vaccine 837
- b4 _/ B6 C; w; e' k38 Yellow fever vaccine 8701 X( R4 K4 m8 V- r: H
39 Zoster vaccine 969& _, m& R* R2 V$ n
40 Combination vaccines 981
+ {$ @1 i- Z6 N/ }6 b& [SECTION 3: Vaccines in development and new vaccine strategies
5 Q2 E& [9 L$ e( `$ |41 Biodefense and special pathogen vaccines 1008
' Y, K, y3 C' |42 Therapeutic cancer vaccines 1018
+ F# ^1 r& F( Y( q5 u* G43 Cytomegalovirus vaccines 10329 R5 e: T  A# y2 W
44 Dengue vaccines 1042
/ g7 j/ {% J8 w& U" |0 n7 d, ?45 Diarrhea caused by bacteria 10521 F* w7 `6 w$ R5 O  M
46 Ebola vaccine 1060- _  E1 b9 @+ n4 T6 k
47 Epstein-Barr virus vaccines 10681 C4 D1 p1 x0 K0 z* P
48 Hepatitis C vaccines 1074
& Q( f2 C1 _! b) W49 Hepatitis E vaccines 1085$ p7 o0 \. [5 d3 i. I# p* ]
50 Herpes simplex virus vaccines 1090
" P# M" H9 I# h( @6 E2 d- X51 Human immunodeficiency virus vaccines 1097
! b$ c' d% S0 |- p" z1 T52 Lyme disease vaccines 11222 d4 G0 T& }8 ^+ f* P& [" |! Z
53 Malaria vaccines 1133
2 ?! ?3 M3 K3 _/ R/ k  b4 {4 w54 Noninfectious disease vaccines 1138( M5 j/ {# N$ k
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146% _6 F) c* T& g0 Z
56 Parasitic disease vaccines 11545 m) r2 t% F1 I5 i# z% u7 d
57 Staphylococcus aureus vaccines 1161  e& I2 A5 l/ n/ q1 C
58 Streptococcus group A vaccines 1169
1 I7 E5 ?1 k& B1 K: G" I/ L59 Streptococcus group B vaccines 1176% g" A; h# n; z  ^2 E; v
60 Technologies for making new vaccines 1182
" [0 y$ g7 C* X3 w( A61 Alternative vaccine delivery methods 1200
) }" u4 d8 a3 l- m62 The development of gene-based vectors for immunization 12320 K/ [) D1 p2 |# s
SECTION 4: Vaccination of special groups; N+ ~* i* o# N% D/ f. L; ]1 J0 v
63 Vaccination of immunocompromised hosts 12438 A+ R9 e- j4 \1 t) l* c* x
64 Vaccination of human immunodeficiency virus-infected persons 12578 r3 m* n( {; l
65 Vaccines for international travel 1270& t0 b& V& U3 Y3 a5 E6 d6 e* C
66 Vaccines for health care personnel 1290- C5 U; ^! |) l9 G/ w4 p/ d2 U
SECTION 5: Public health and regulatory issues6 c" Y+ V& k1 O+ w% u
67 Immunization in the United States 13103 g* x5 e. {1 R; X& S7 N
68 Immunization in Europe . 1334
1 H* ^% y! X7 R69 Immunization in the Asia-Pacific region 1353
8 B: e2 W8 Q" c, f70 Immunization in developing countries 1369+ W+ q2 o- i" {9 i
71 Community immunity 1395
! H! O* y& F$ t72 Economic analyses of vaccine policies 14130 K# m" t3 C) s) C
73 Regulation and testing of vaccines 1427
* L& Z( j/ P; s9 X. \: l- p1 V74 Regulation of vaccines in Europe 1447
% Q* y- K* x. @+ K75 Regulation of vaccines in developing countries 14543 p# t1 `) |6 u
76 Vaccine safety 14646 A2 ~# G% p# d# W) |
77 Legal issues . 1481
. s, X& R; `- D, u$ b/ Q) O/ q78 Ethics 1508! h6 F) K$ [0 X. {- @) P$ W7 K
3 O2 w8 l$ d& i- ^; s, t
2 L+ Y/ ]2 L3 N# q7 ]

6 c- P  I- V2 c) ~% V  L

. a8 H" Q; N& ]  t: J) O
分享到:  QQ好友和群QQ好友和群 QQ空间QQ空间 腾讯微博腾讯微博 腾讯朋友腾讯朋友
收藏收藏 分享分享 支持支持 反对反对

7

帖子

2

学分

357

金币

病毒学院小学生

Rank: 2Rank: 2

积分
2
沙发
发表于 2015-7-26 14:55:58 | 只看该作者
非常感谢

36

帖子

27

学分

3544

金币

病毒学院中学生

Rank: 3Rank: 3Rank: 3

积分
27
板凳
发表于 2015-8-13 17:54:21 | 只看该作者
谢谢分享

36

帖子

27

学分

3544

金币

病毒学院中学生

Rank: 3Rank: 3Rank: 3

积分
27
地板
发表于 2015-8-13 17:55:46 | 只看该作者
怎么看不到相关下载呀

1067

帖子

1032

学分

1万

金币

管理员

Rank: 9Rank: 9Rank: 9Rank: 9

积分
1032
QQ
5#
 楼主| 发表于 2015-8-13 21:26:48 | 只看该作者
+ H3 B" B0 a  ?+ \% B
Vaccines, 6th Edition6 M( M! I1 B0 _* }& l

* j' T, x/ o+ M& D6 [Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.- s' s7 k9 f0 l3 P

. E% _$ D- o# @' U. I+ {5 Chttp://yun.baidu.com/share/link? ... 1&uk=3810996606
3 V' N. V, B3 A. B3 l8 I- A
; h* U% L; {3 i: x& h' [! v1 r' p' OSECTION 1: General aspects of vaccination
5 Y6 g, S8 [0 }, |6 {: X% ^" ~& ~1 A short history of vaccination 1
# Q" t$ U' Q7 ]% Z- g( q+ l8 J6 c2 Vaccine immunology 14% \$ r5 s& v( b3 {! r6 b
3 The vaccine industry 33% t2 W8 F0 }: j# q/ O/ n: R. {
4 Vaccine manufacturing 44
9 p2 N# T# w' }( r; g# H- \5 Evolution of adjuvants across the centuries 588 [$ C9 ]4 ^; t8 f, L  D
6 Vaccine additives and manufacturing residuals in the United States:
- E9 h! @. x; [9 Klicensed vaccines 71: G1 @1 L1 V: Y# l  M* S
7 Passive immunization 80
) v/ n* O8 M& P3 x, P2 X8 General immunization practices 88
6 R+ X9 Y  Z2 zSECTION 2: Licensed vaccines+ T) N) t" Y. a
9 Adenovirus vaccines 1132 V* T: ^7 k! \' B. n
10 Anthrax vaccines 127, h: t: q- H7 m& L7 ?( b2 O0 ?
11 Cholera vaccines 141
% V+ F* [$ n2 {' F* I$ ?* y12 Diphtheria toxoid 153+ T' b1 T9 @3 `" |6 }7 ]* J
13 Haemophilus influenzae vaccines 167* \1 x, r* C: s/ i, K  Y
14 Hepatitis A vaccines 183
8 E& S( K$ X8 X5 {15 Hepatitis B vaccines 205" d* H! n6 H; o# Z
16 Human papillomavirus vaccines 235
, ?0 }8 i" A$ d17 Inactivated influenza vaccines 257
' T( q4 G) V3 a9 ~5 P18 Influenza vaccine-live 294  C( u$ x7 {1 y- L9 p. x, D
19 Japanese encephalitis vaccines 312
0 Z& ~/ x# b- x% K, y" k20 Measles vaccines 352
! S# X( g. f. F" p5 u0 z21 Meningococcal vaccines 388
# @: C! `, @3 v% _# E22 Mumps vaccine 419
, u, o3 P3 P( g9 W# Z- O2 b4 e" a23 Pertussis vaccines . 447
: N  g7 e& l# L/ ^+ M24 Plague vaccines 493
" h9 X) E, f6 i25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
. N% [' ]% c% O: d9 m8 m, f26 Pneumococcal polysaccharide vaccines 542
7 W4 i# i2 N" C) ~4 `. C, h4 F& F27 Poliovirus vaccine-inactivated . 573
3 Z$ n" ], y' A% K& [28 Poliovirus vaccine-live 598
' Y; i$ K4 E; S, }- f2 t( P$ r29 Rabies vaccines .646
8 i% Q% ^3 c5 I2 W: \. X2 @30 Rotavirus vaccines . 669- g  ~8 _' d. u
31 Rubella vaccine 688, N0 K" G7 {7 M, ^
32 Smallpox and vaccinia 718, u7 ?  K5 J; x% @  |
33 Tetanus toxoid 746
0 n: x7 k$ s7 J1 r9 G' i34 Tick-borne encephalitis virus vaccines 773
7 `  k# l5 }. g35 Tuberculosis vaccines 789
/ f( C7 q, w5 u3 ?36 Typhoid fever vaccines 812- x7 x: @" j# p) j* x
37 Varicella vaccine 837
$ ^' n& J* V3 n38 Yellow fever vaccine 8704 ~3 v( F, G3 Y6 |
39 Zoster vaccine 969( ^( Z  r- T" S- d4 \2 `& a
40 Combination vaccines 981
/ W' [& b' h7 wSECTION 3: Vaccines in development and new vaccine strategies
' E/ @. T0 o- t) k1 I41 Biodefense and special pathogen vaccines 1008
/ v- c' X9 @" o8 q6 _" m/ v: R42 Therapeutic cancer vaccines 10186 V( i$ [0 K6 }" v& F
43 Cytomegalovirus vaccines 1032  [5 |1 c4 k# q
44 Dengue vaccines 1042$ T, i+ j1 O# G5 G- K
45 Diarrhea caused by bacteria 1052; a( h7 Q! B( ~4 ^
46 Ebola vaccine 1060
4 Y4 X; d  b+ _47 Epstein-Barr virus vaccines 1068
  @, r2 l0 r2 }; E48 Hepatitis C vaccines 10747 t; K0 W' T& q8 ]9 Q
49 Hepatitis E vaccines 1085
( v7 I1 M& `% |+ V6 s1 E( F9 G: b+ m50 Herpes simplex virus vaccines 1090  i' }3 N7 s$ a/ J  Q' `' a/ F
51 Human immunodeficiency virus vaccines 1097
8 Z: m" V0 I; E" b. j  b; ~52 Lyme disease vaccines 11220 w6 P* R+ Y+ u6 d/ a9 ~6 \; X. Z
53 Malaria vaccines 1133
* @/ Q  U0 @6 f: S8 _7 u' j; I7 C54 Noninfectious disease vaccines 1138
$ ?6 H* V4 z0 j1 R( T55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
5 M# X) I5 D" O. c( J56 Parasitic disease vaccines 1154
* f- i; Y' P" t: i/ o/ e57 Staphylococcus aureus vaccines 11616 ^1 g6 v2 B; V: X8 p
58 Streptococcus group A vaccines 1169' m# p5 M% N- F+ O) N& H
59 Streptococcus group B vaccines 1176
  H$ R) f" {: ^) d) m3 @* a60 Technologies for making new vaccines 11823 O- t. S" @, b* Q+ j5 E' ]
61 Alternative vaccine delivery methods 12004 M/ y5 w2 D. m0 j& p5 D' `9 B2 ^( I
62 The development of gene-based vectors for immunization 1232  }" o0 G% X3 y" y
SECTION 4: Vaccination of special groups
5 K2 A- n. w# j8 s7 M8 R63 Vaccination of immunocompromised hosts 1243
8 [% e9 ^6 O5 [* S# k# Q64 Vaccination of human immunodeficiency virus-infected persons 1257
6 `1 v, j; t5 S2 J65 Vaccines for international travel 1270# Q+ ]! q5 m) r- }$ Y# {
66 Vaccines for health care personnel 1290, ^/ O; T# x2 o$ A: h
SECTION 5: Public health and regulatory issues5 y1 _  w/ D! d7 M/ K# K- m8 i/ i
67 Immunization in the United States 13107 M1 w* z9 l& q# H4 f$ Y
68 Immunization in Europe . 1334
# @$ e* h6 i" |* y% X69 Immunization in the Asia-Pacific region 1353
. m! ^+ m  m  E% _; n70 Immunization in developing countries 1369" }; Y" N! `4 K9 B0 y' o
71 Community immunity 1395
/ G6 G( _) d  h$ r$ n/ g! |72 Economic analyses of vaccine policies 1413. L1 e  G# V/ q6 X: b& z- T
73 Regulation and testing of vaccines 1427
9 o1 ?$ u6 [/ }+ H$ x74 Regulation of vaccines in Europe 1447* G# ?3 n' Z5 w6 j- M
75 Regulation of vaccines in developing countries 1454. s4 ~+ T% q! F4 z9 B
76 Vaccine safety 1464) ~9 Y3 v0 g* n9 t1 g. ]5 N9 a3 C
77 Legal issues . 1481
4 a9 C6 K0 v1 I; \/ n78 Ethics 1508  _0 w5 F3 C) A* |" n  \

$ G% S8 N0 [& O; a- ~' b9 B9 o$ N3 B2 h$ G& k. L% \- t" K

23

帖子

39

学分

5741

金币

病毒学院中学生

Rank: 3Rank: 3Rank: 3

积分
39
6#
发表于 2017-5-2 15:25:27 | 只看该作者
Vaccines, 6e, 2012* |/ D$ t* E2 x1 R
; F; ]. |* l/ Q3 i8 n, Z- @
Hardcover: 1570 pages  C3 v# Y- Y$ L( O* i+ X
Publisher: Saunders; 6 edition (October 30, 2012)
5 A" X; ]( I; l1 J: }& e! MLanguage: English  N# r% ]2 z( B) G" B9 h
ISBN-10: 1455700908
) J: Q; [' T% }Size: 52.3mb (original pdf)9 @$ U7 H( Y+ Z" _! `, N

% D# P# J+ z+ `3 o8 x5 X2013 BMA Medical Book Awards Highly Commended in Public Health!: d" f* w3 ~( _! |3 }
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
) s6 w5 z  i+ [, d
  A& M% \. [& V5 O& gGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.% u" n  @& K4 M7 y7 r" a
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.0 ]/ f; d7 A! S' _$ z
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies." e) N' k6 u, B/ ]9 Q& h+ o% s5 ~
Analyze the cost-benefit and cost-effectiveness of different vaccine options.; h7 W. ]) N, G9 ~6 r6 l" [/ g7 V0 P
Clearly visualize concepts and objective data through an abundance of tables and figures.
, D% G# E6 Q! w: _Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.2 _' B9 V4 I6 S- i0 w
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.: ]7 ^4 E. `4 y* F' L
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.# m$ a" f- M0 \  ]* ]8 f( n
3 m# a' v) g5 |  h* s1 Q  o
Download link: http://pan.baidu.com/s/1i5NxwLR ! Q$ K/ D1 N# U: A$ b7 P
Code for downloading: dv96
, ?9 u. F' z; r5 p$ S" J
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

QQ|论坛App下载|Archiver|小黑屋|中国病毒学论坛    

GMT+8, 2024-11-25 18:31 , Processed in 0.213026 second(s), 29 queries .

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表